Chesley Taft & Associates LLC reduced its position in Express Scripts Holding (NASDAQ:ESRX) by 3.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 74,615 shares of the company’s stock after selling 2,774 shares during the period. Chesley Taft & Associates LLC’s holdings in Express Scripts were worth $5,569,000 as of its most recent filing with the SEC.
A number of other large investors have also recently modified their holdings of ESRX. Burt Wealth Advisors lifted its position in Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after acquiring an additional 174 shares during the last quarter. Bank of Nova Scotia Trust Co. acquired a new stake in Express Scripts during the third quarter worth approximately $120,000. Monroe Bank & Trust MI lifted its position in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after acquiring an additional 970 shares during the last quarter. Capstone Investment Advisors Netherlands B.V. lifted its position in Express Scripts by 49.3% during the second quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock worth $179,000 after acquiring an additional 924 shares during the last quarter. Finally, Nelson Roberts Investment Advisors LLC acquired a new stake in Express Scripts during the third quarter worth approximately $193,000. Institutional investors and hedge funds own 88.28% of the company’s stock.
Several brokerages have issued reports on ESRX. SunTrust Banks set a $82.00 price objective on shares of Express Scripts and gave the stock a “buy” rating in a research report on Thursday, December 14th. Jefferies Group restated a “buy” rating on shares of Express Scripts in a research report on Thursday, October 26th. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price objective for the company in a research report on Monday, October 16th. Royal Bank of Canada set a $68.00 price objective on shares of Express Scripts and gave the stock a “hold” rating in a research report on Friday, December 15th. Finally, Evercore ISI began coverage on shares of Express Scripts in a research report on Thursday, January 4th. They set an “in-line” rating and a $78.00 price objective for the company. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $76.52.
Shares of Express Scripts Holding (NASDAQ ESRX) traded up $3.35 on Wednesday, hitting $79.91. 6,904,800 shares of the stock traded hands, compared to its average volume of 3,561,033. Express Scripts Holding has a 12 month low of $55.80 and a 12 month high of $80.00. The company has a market capitalization of $45,260.00, a PE ratio of 13.27, a PEG ratio of 1.01 and a beta of 0.87. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.90. The business had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period last year, the firm posted $1.74 earnings per share. sell-side analysts forecast that Express Scripts Holding will post 7.04 EPS for the current year.
Express Scripts declared that its Board of Directors has initiated a share repurchase plan on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.
In related news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Timothy C. Wentworth acquired 8,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 31st. The stock was purchased at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the completion of the purchase, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. Insiders sold 14,195 shares of company stock worth $1,010,240 over the last three months. 0.68% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Express Scripts Holding (ESRX) Position Cut by Chesley Taft & Associates LLC” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/10/express-scripts-holding-esrx-position-cut-by-chesley-taft-associates-llc.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.